Quality control is paramount in biopharmaceutical development to ensure the safety, efficacy, and consistency of therapeutic products. Robust DNA, RNA, and protein quality control measures are essential for mitigating risks, enhancing product quality, ensuring compliance with regulations and delivering safe and effective biopharmaceutical products to patients. Avance Biosciences™ offers state-of-the-art solutions for DNA, RNA, and protein quality control, leveraging advanced platforms such as the NanoDrop 1000 Spectrophotometer, NanoDrop One Spectrophotometer, and Agilent 2100 Bioanalyzer.

NanoDrop 1000 Spectrophotometer:

The NanoDrop 1000 Spectrophotometer is a compact and versatile instrument designed for rapid and accurate quantification of nucleic acids and proteins.

NanoDrop One Spectrophotometer:

The NanoDrop One Spectrophotometer represents the next generation of spectrophotometry technology, offering enhanced performance, versatility, and connectivity for DNA, RNA, and protein analysis.

Agilent 2100 Bioanalyzer:

The Agilent 2100 Bioanalyzer is a high-performance microfluidic electrophoresis system designed for automated analysis of DNA, RNA, and proteins.

Avance Biosciences™ leverages the advanced capabilities of the NanoDrop 1000 Spectrophotometer, NanoDrop One Spectrophotometer, and Agilent 2100 Bioanalyzer to provide comprehensive solutions for DNA, RNA, and protein quality control in biopharmaceutical development. For rapid quantification, advanced optical performance, and multiplex analysis, our platforms are equipped to meet quality control needs with accuracy, efficiency, and reliability. Contact us today to learn more about how we can support your biopharmaceutical development initiatives.


When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!


Dedication to Quality

Dedication To Quality

The Avance Biosciences™ team is committed to strict adherence to CGMP and GLP regulations enacted by the US, European, Japanese, and other international regulatory agencies.


Extensive Experience

Open Communication

Our team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 100 pharmaceutical and biotechnology companies and organizations throughout the world.


Open Communication

Open Communication

Transparency and integrity are two of our core values. Our well-trained, friendly, and professional study directors and project managers strive to complete your projects on-time with open communication channels and to your specifications.


Cutting Edge Science

Open Communication

Avance Biosciences™’ CGMP/GLP compliant genomic and microbial assays make use of the advanced technologies including real-time PCR, ddPCR, Sanger sequencing, next-gen sequencing, Southern blot, and more.